What You Should Know:
- Reprieve Cardiovascular, a clinical-stage company secures $61M in Series B funding led by Deerfield Management and included participation from several other investors, such as Arboretum Ventures, Lightstone Ventures, and an undisclosed strategic investor.
- The funding round, which combines equity investment with a debt facility will be used to support the rapid execution of the global FASTR II pivotal clinical trial and to fund key commercial readiness
Read More
Heart Disease | Transforming Heart Disease through Medical Technology for Patients
Ultromics Secures $55M to Expand AI-Driven Cardiology Solutions for Heart Failure
What You Should Know:
- Ultromics, a pioneer in AI-driven cardiology solutions secures $55M in Series C financing co-led by L&G, Allegis Capital, and Lightrock, with continued support from Oxford Science Enterprises, GV, Blue Venture Fund, and Oxford University. Major U.S. health systems, including University of Chicago Medicine and UCM Ventures, also participated in the round.
- Built on years of clinical study and hundreds of thousands of echo scans, Ultromics offers the first
Read More
American Heart Association Ventures™ Invests in Auxira Health to Transform Cardiology Care
What You Should Know:
- Auxira Health, a virtual cardiology platform announced a strategic collaboration with and investment from American Heart Association Ventures™, the venture capital arm of the American Heart Association®. Both organizations share a commitment to improving patient outcomes by better aligning incentives between providers and patients.
- Auxira, initially co-developed by MedStar Health and Abundant Venture Partners, launched earlier this year to address the
Read More
Boehringer Ingelheim and Eko Health Partner to Bring AI-Powered Heart Disease Detection to Veterinary Medicine
What You Should Know:
- Boehringer Ingelheim, a global leader in animal health, and Eko Health, a pioneer in applying artificial intelligence (AI) for early disease detection, have announced a strategic collaboration. The partnership aims to enhance the early detection and diagnosis of heart disease in dogs by combining Boehringer's expertise in canine cardiology with Eko Health's powerful AI algorithms and digital stethoscopes.
- The collaboration will leverage Eko Health's
Read More
AliveCor Unveils KardiaMobile 6L Max & KardiaAlert for Advanced Personal ECG Monitoring
What You Should Know:
- AliveCor, a leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced the launch of its most advanced personal ECG system, the AI-powered KardiaMobile® 6L Max.
- Accompanying this device is KardiaAlert™, a first-of-its-kind feature available exclusively to subscribers of AliveCor's KardiaCare service. Together, these innovations aim to provide users with more comprehensive detections and insights, monitor heart rhythms for
Read More
Heart Failure’s Hidden Price: Understanding the True Cost of Cardiac Events and AI’s Role in Reducing Expenses
Cardiovascular disease (CVD) is a leading cause of death and a growing financial strain on the U.S. healthcare system, costing an estimated $252.2 billion annually. With one in every eight healthcare dollars spent on cardiac care, the urgency to control costs while improving patient outcomes has never been greater.
As traditional care models struggle to keep up with demand, we are faced with an important question: How can we make cardiac care more sustainable, ensuring the healthcare
Read More
HeartFlow and Boone Heart Institute Launch GAMEFILM Registry to Study Heart Health in Retired NFL Players
What You Should Know:
- HeartFlow, a global leader in AI-driven heart care solutions, and Boone Heart Institute, a renowned cardiovascular care provider in Denver, today announced the launch of the GAMEFILM Registry.
- GAMEFILM Registry will utilize advanced imaging and AI technology to assess and better understand coronary artery disease (CAD) risk in retired National Football League (NFL) players.
Understanding the Unique Cardiovascular Risks of Retired NFL
Read More
Mayo Clinic, SandboxAQ Expand Collaboration to Advance AI Cardiac Diagnostics in Amyloidosis
What You Should Know:
- Mayo Clinic is expanding its collaboration with SandboxAQ, a provider of artificial intelligence (AI) medical apps to explore the use of electrocardiography (ECG) and magnetocardiography (MCG) technologies for characterizing disease progression and treatment response in patients with amyloidosis.
- The expanded partnership highlights the potential of combining AI and advanced sensing technology to revolutionize cardiac diagnostics.
Improved Detection and
Read More
FIRE1 Secures $120M for Heart Failure Management Platform
What You Should Know:
- FIRE1, a connected medical device company, announced it has secured $120M in funding to advance its mission to transform the lives of millions of people living with heart failure. The round was led by Polaris Partners and Elevage Medical Technologies, joined by new investors Sands Capital and Longitude Capital, and existing investors Andera Partners, Gilde Healthcare, Gimv, the Ireland Strategic Investment Fund, Lightstone Ventures, Medtronic, NEA (New Enterprise
Read More
Abbott Launches Clinical Trial to Optimize Heart Failure Treatment with AI-Powered Monitoring
What You Should Know:
- Abbott, a global healthcare leader, has announced a new clinical trial, TEAM-HF, designed to improve outcomes for patients with worsening heart failure.
- The first-of-its-kind trial will leverage AI and Abbott's CardioMEMS™ HF System to identify patients who may benefit from earlier intervention with advanced therapies, such as a HeartMate 3™ left ventricular assist device (LVAD).
Addressing the Challenges of Advanced Heart Failure
Heart
Read More
